Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 85 publications
Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Journal: Annals of internal medicine
Published: June 29, 2026
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.
Journal: Nature medicine
Published: June 24, 2026
Survodutide Once Weekly for the Treatment of Adults with Obesity.
Journal: The New England journal of medicine
Published: June 08, 2026
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial.
Journal: Nature medicine
Published: April 22, 2026
Once-Monthly Maridebart Cafraglutide in Obesity - A Phase 2 Trial. Reply.
Journal: The New England journal of medicine
Published: December 03, 2025
Naltrexone/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms.
Journal: Drug and alcohol dependence reports
Published: November 06, 2025
Semaglutide and Tirzepatide Prescribing for Obesity in Patients With Preexisting Comorbid Cancers.
Journal: JAMA oncology
Published: November 06, 2025
Last Updated: 09/26/2026